Shares are expected to be credited to successful bidders’ demat accounts on June 2, with the stock set to list on the BSE SME platform on June 3.
The IPO saw a moderate overall subscription of 1.79 times. The retail portion was subscribed 1.69 times, and the non-institutional investor (NII) category showed relatively stronger interest at 5.60 times.
However, the Qualified Institutional Buyers (QIB) segment remained underwhelming, with bids covering just 70% of the allocated quota. This uneven demand, especially weak QIB participation, may weigh on listing day sentiment.
Adding to the subdued tone is the latest grey market premium (GMP) for Astonea Labs IPO, which stands at zero. This suggests that the stock may list around its issue price of Rs 135 per share, with no significant listing gains expected as of now.
How to Check Astonea Labs IPO Allotment on BSE:Visit: https://www.bseindia.com/investors/appli_check.aspxSelect ‘Equity’ and ‘Astonea Labs’ from the dropdown.Enter your application number or PAN.Click ‘Search’ to view the allotment status.
Check via KFin Technologies (Registrar):
Visit: https://ris.kfintech.com/ipostatus/Choose ‘Astonea Labs IPO’Enter your PAN, application number, or DP/client ID.Click ‘Submit’ to view your allotment.
Astonea Labs is a contract manufacturer of pharmaceutical and cosmetic products and also markets its own brands like “Glow Up” and “Regero”.
The company has a presence in both domestic and export markets, including countries like Iraq and Yemen. Proceeds from the IPO will go towards registration expansion in Bolivia, installation of machinery for international-standard ointment production, advertising, tech upgrades, and working capital.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of Economic Times)
